Edition:
India

Verona Pharma PLC (VRNA.OQ)

VRNA.OQ on NASDAQ Stock Exchange Global Market

13.04USD
18 Jan 2018
Change (% chg)

$0.24 (+1.88%)
Prev Close
$12.80
Open
$12.99
Day's High
$13.40
Day's Low
$12.99
Volume
1,104
Avg. Vol
1,560
52-wk High
$17.50
52-wk Low
$10.44

Select another date:

Thu, Sep 7 2017

BRIEF-Verona Pharma announces positive top-line data from Phase 2A clinical trial in COPD with RPL554 dosed in addition to Tiotropium

* ANNOUNCES POSITIVE TOP-LINE DATA FROM PHASE 2A CLINICAL TRIAL IN COPD WITH RPL554 DOSED IN ADDITION TO TIOTROPIUM (SPIRIVA) Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Select another date: